PriceTargets.com logo

NASDAQ:NUWE - Nuwellis Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $7.50
  • Forecasted Upside: 733.33 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$0.90 As of 03/11/2022 05:00 PM ET
▼ -0.02 (-2.17%)

This chart shows the closing price for NUWE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Nuwellis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NUWE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NUWE

Analyst Price Target is $7.50
▲ +733.33% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Nuwellis in the last 3 months. The average price target is $7.50, with a high forecast of $9.00 and a low forecast of $6.00. The average price target represents a 733.33% upside from the last price of $0.90.

This chart shows the closing price for NUWE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Nuwellis.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/13/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/12/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/10/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/12/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2021Maxim GroupLower Price TargetPositive ➝ Buy$12.00 ➝ $6.00High
9/7/2021Lake Street CapitalInitiated CoverageBuy$9.00Low
(Data available from 3/12/2017 forward)

News Sentiment Rating

0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/14/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/13/2021
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/13/2021
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/12/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/12/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/11/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/10/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/12/2022

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Nuwellis logo
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Read More

Today's Range

Now: $0.90
Low: $0.85
High: $1.17

50 Day Range

MA: $1.06
Low: $0.87
High: $1.27

52 Week Range

Now: $0.90
Low: $0.82
High: $8.41

Volume

870,251 shs

Average Volume

128,059 shs

Market Capitalization

$9.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Nuwellis?

The following sell-side analysts have issued stock ratings on Nuwellis in the last twelve months: Lake Street Capital, Maxim Group, and Zacks Investment Research.
View the latest analyst ratings for NUWE.

What is the current price target for Nuwellis?

2 Wall Street analysts have set twelve-month price targets for Nuwellis in the last year. Their average twelve-month price target is $7.50, suggesting a possible upside of 733.3%. Lake Street Capital has the highest price target set, predicting NUWE will reach $9.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $6.00 for Nuwellis in the next year.
View the latest price targets for NUWE.

What is the current consensus analyst rating for Nuwellis?

Nuwellis currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NUWE will outperform the market and that investors should add to their positions of Nuwellis.
View the latest ratings for NUWE.

How do I contact Nuwellis' investor relations team?

Nuwellis' physical mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company's listed phone number is (952) 345-4200 and its investor relations email address is [email protected] The official website for Nuwellis is www.nuwellis.com. Learn More about contacing Nuwellis investor relations.